When Evidence Drives Adoption: How Investors Evaluate Diagnostic, Device, and MedTech Innovation in a Policy Constrained Market

July 30, 2026

Back to all webinars

Title: When Evidence Drives Adoption: How Investors Evaluate Diagnostic, Device, and MedTech Innovation in a Policy Constrained Market

Thursday, July 30, 2026
11:00AM EDT | 3:00PM UTC | 5:00PM CEST

Click here for time zone conversion

Registration Coming Soon!

Description

Diagnostics, medical devices, and MedTech innovations face distinct evidence, payment, and adoption challenges compared with pharmaceuticals—yet investors apply increasingly rigorous standards when assessing their commercial and clinical viability. This webinar examines how investors evaluate evidence for diagnostic and device technologies in the context of evolving reimbursement pathways, regulatory requirements, and health system purchasing behavior. Panelists will discuss what constitutes “investment‑grade” evidence for MedTech, where promising technologies struggle to demonstrate durable value, and how policy and coverage dynamics shape investor underwriting decisions. The discussion highlights how evidence expectations differ across innovation types and sets the stage for deeper exploration at the ISPOR Healthcare Investment Summit.

Learning Objectives

  • Understand how investors evaluate “investment‑grade” evidence for diagnostics, medical devices, and MedTech innovations, including the role of clinical, economic, and real-world data in underwriting decisions.
  • Identify key evidence and market access risks that influence valuation, reimbursement, and adoption—particularly how policy, coverage pathways, and health system behavior shape commercial outcomes.
  • Apply HEOR and value demonstration principles to better align evidence generation strategies with investor expectations, improving the likelihood that innovations are both fundable and scalable.

Moderator:

Erik Landaas, PhD, MPH, Global Director HEOR, Cardiac, W. L. Gore & Associates, Inc., Newark, DE, USA 

Speakers:

Ryan D. Lynch, MBA, Associate, Sandbox Industries; Blue Venture Fund, Chicago, IL, USA

James Reinstein, Chief Executive Officer, Conformal Medical, Inc., Nashua, NH, USA

 

Brought to you by  ISPOR.

Please note: On the day of the scheduled webinar, the first 1000 registered participants will be accepted into the webinar. For those who are unable to attend, or would like to review the webinar at a later date, the full-length webinar recording will be made available at the ISPOR Educational Webinar Series webpage approximately 2 days after the scheduled Webinar. Reservations are on a first-come, first-served basis.

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×